Aloe Skin Randomized Trial: What the Evidence Says

Quick Answer

Aloe Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Lasers and light-based therapies have been frequently applied to treat AE; offering a quicker response and reduced acne sequelae. [Boonpethkaew Suphagan (2026); evidence level 2]
• AE grade reduction progressively improved among responders, whereas no significant improvement was observed among non-responders (Figure ). [Boonpethkaew Suphagan (2026); evidence level 2]
• The risk of dental caries increases with the continuous consumption of carbohydrates and sugar, resulting in increased acidity and disruption of the oral microbial balance. [Irmaleny Irmaleny (2026); evidence level 3]
• However, CPP-ACP has a drawback-it poses a high risk for lactose-intolerant individuals and is expensive. [Irmaleny Irmaleny (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For aloe skin randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Boonpethkaew Suphagan (2026). Efficacy and Safety of a Dual‐Wavelength 589/1319 nm Laser for the Treatment of Acne Erythema: A Split‐Face Randomized Controlled Trial. DOI: 10.1111/jocd.70894. PMCID: PMC13145309. PMID: 42087432. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13145309/
• Irmaleny Irmaleny (2026). The Potential of Aloe vera as a Caries Prevention Agent in the Future: A Scoping Review. DOI: 10.3390/jcm15124744. PMCID: PMC13302088. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13302088/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.